Medical device company ResMed (NYSE:RMD) announced in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its ...

Medical technology company Stryker (NYSE:SYK) reported in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per share was 3.5% above analysts’ consensus ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

Apple is still facing headwinds in China. The company's overall sales in China declined 11.1% during to $18.51 billion during ...

Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...

The company that operates an East Liverpool hazardous waste incinerator with a history of regulatory issues has added a ...

MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...

We spoke with Humanity CEO Terence Kwok to explore how the company plans to address security and privacy issues.

Wolfspeed ( WOLF -9.29%) was once a red-hot chip stock. The company had established an early-mover advantage in silicon ...

A recent study identified 157 cardiovascular devices recalled from 2013 to 2022. Recalls were commonly attributed to device ...